Senior-Led Strategy for High-Consequence Pharmaceutical Commercialization Decisions

PSS supported a top-tier diagnostic manufacturer in the architectural design and implementation planning for a nationwide sponsored testing program.. The engagement focused on bridging the gap between patient identification and treatment initiation through lab partner coordination and streamlined logistics. PSS provided implementation governance and cross-functional oversight, ensuring data integration across lab networks and field team readiness. The resulting operating model provided leadership with clear visibility into program KPIs and testing-to-treatment progression.

An innovator brand team engaged PSS to develop a multi-year loss-of-exclusivity (LoE) strategy for a primary care asset. PSS delivered comprehensive erosion modeling and a scenario-based pricing framework to evaluate authorized generic and brand-for-generic partnership models. The strategy included channel-specific response plans and trade/distribution adjustments to evaluate and seek to preserve portfolio economics post-LoE. PSS translated strategic recommendations into a decision-ready roadmap, coordinating internal stakeholders to ensure operational alignment ahead of competitive entry.

PSS provided commercialization governance for an innovator launching an unbranded biologic under an existing BLA. The scope included specialty pharmacy channel design, payer sequencing, and WAC/pricing strategy coordination. PSS coordinated operational readiness workstreams, aligning packaging, labeling, and 3PL partners. The centralized governance structure supported the client in managing a dual-branded portfolio while tracking supply chain integrity and market access milestones.